PODDInsulet Corporation

SPX

Data as of Oct 15, 2026 · 09:38 p.m.

$138.77

+3.61%

Unlock full analysis
51/100
● Neutral Zone

No directional signal

The canonical InvestCompass profile currently shows mixed evidence without a clear directional edge.

Global score threshold

Buy Zone ≥ 80
Partial Buy Zone ≥ 65
Neutral Zone ≥ 45
Partial Sell Zone ≥ 25
Sell Zone < 25

Insulet Corporation

PODD
Market
SPX
Sector:
Healthcare
Industry
Medical Devices

About the company

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Global score detail

Breakdown of the 4 modules in the global score (Macro, Sector, Fundamental, Technical)

1. Macro(15%)57/100
Sector(30%)45/100
Fundamental(25%)81/100
Technical(30%)27/100
Macro — Full analysis workspace
Fundamental — Full analysis workspace
Sector — Full analysis workspace
Technical — Full analysis workspace
Fundamentals and peer comparison
Signals and trade plan

Current Price

$138.77

Period High

$354.88

Period Low

$126.40

Analyst Target

$167.17

20.5% upside

Price history

Loading chart...

Moving averages
Technical indicators
Technical indicators
Technical indicators
Technical indicators
Moving averages
Technical indicators
AI and news commentary
AI and news commentary

InvestCompass provides analysis tools, not financial advice. Data may be delayed.